TY - JOUR
T1 - A joint procedural position statement on imaging in cardiac sarcoidosis
T2 - from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology
AU - Slart, Riemer H. J. A.
AU - Glaudemans, Andor W. J. M.
AU - Lancellotti, Patrizio
AU - Hyafil, Fabien
AU - Blankstein, Ron
AU - Schwartz, Ronald G.
AU - Jaber, Wael A.
AU - Russell, Raymond
AU - Gimelli, Alessia
AU - Rouzet, Francois
AU - Hacker, Marcus
AU - Gheysens, Olivier
AU - Plein, Sven
AU - Miller, Edward J.
AU - Dorbala, Sharmila
AU - Donal, Erwan
AU - Sciagra, Roberto
AU - Bucerius, Jan
AU - Verberne, Hein J.
AU - Lindner, Oliver
AU - Uebleis, Christopher
AU - Agostini, Denis
AU - Signore, Alberto
AU - Edvardsen, Thor
AU - Neglia, Danilo
AU - Beanlands, Rob S.
AU - Di Carli, Marcelo
AU - Chareonthaitawee, Panithaya
AU - Dilsizian, Vasken
AU - Soman, Prem
AU - Habib, Gilbert
PY - 2017/10
Y1 - 2017/10
N2 - This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with F-18-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
AB - This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with F-18-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
KW - POSITRON-EMISSION-TOMOGRAPHY
KW - LATE GADOLINIUM ENHANCEMENT
KW - SPECKLE-TRACKING ECHOCARDIOGRAPHY
KW - MYOCARDIAL FDG UPTAKE
KW - MAGNETIC-RESONANCE
KW - SYSTEMIC SARCOIDOSIS
KW - F-18-FDG PET
KW - HYPERTROPHIC CARDIOMYOPATHY
KW - STRAIN ECHOCARDIOGRAPHY
KW - CORTICOSTEROID-THERAPY
U2 - 10.1093/ehjci/jex146
DO - 10.1093/ehjci/jex146
M3 - Article
C2 - 28984894
SN - 2047-2404
VL - 18
SP - 1073
EP - 1089
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 10
ER -